The Journal is Indexed in
9 - Results of our study of treatment for non-small cell lung cancer
Ahmet Uyanoğlu, Didem Karaçetin, Özlem Maral, Kubilay İnanç, Oktay İncekara
OBJECTIVE: Evaluation of treatment and follow up patients with nonsmall cell lung cancer at our clinic between the years of 1989-1997.
STUDY DESIGN: A total of450 patients who were treated and followed up our clinic for more than 6 months of period of time were retrospectively scruntinized. Patients were classified according to general conditions, stages and treatment methods applied and we used ki-square statistical method in our calculations.
RESULTS: Oldest patient was 77, the youngest was 18. Avarage age was 55, the median age was found, to be 57 years. 49 % of patients were in the age group of 51-65; 437 patients were male, 13 were female. The most common (72.9 %- 328 patients) hystologic type was: Epidermoid cancer. Weight loss found to be small 71.3 % had 10 % weight loss. 30 patients, in stage 1 and 2, were treated with surgery, 38 patients were inoperable 56 patients received no chemotheraphy, the patients receiving chemotheraphy, as follows: ICE protocol (Iphosphamide, Cisplatinum, Etoposide) and cisplatinum + etoposide. 224 patients conventionel 50- 70 Gy dosage external radiotherapy, 56 patients received palliative radiotherapy. From all patients, 84 patients were observed with progression, 56 patients had métastasés. Average métastasés apperency duration calculated to be 4.6 months.
CONCLUSION: Lung cancer is the deadliest and most common type of cancer. The applied method of treatment: Local radiotherapy and systemic chemotherapy can be used as a cure or palliation.
Keywords: Nonsmall cell lung cancer, radiotherapy, chemotherapy.
To read full article click